Non-Performing Assets / Total Loans: A classification used by financial institutions that refer to loans that are in jeopardy of default as a potion of total loans made. Calculated as: Non-Perfroming Assets / Gross Loans Made
Kyverna Therapeutics, Inc. (KYTX) Non-Performing Assets / Total Loans data is not available.
| Income Statement Financials | |
-- |
|
$-38.32M |
|
-- |
|
-- |
|
$39.56M |
|
$-39.56M |
|
$1.24M |
|
$-38.32M |
|
$-38.32M |
|
$-38.32M |
|
$-38.32M |
|
$-38.32M |
|
$-38.32M |
|
$-39.56M |
|
$-39.12M |
|
60.90M |
|
60.90M |
|
$-0.63 |
|
$-0.63 |
|
| Balance Sheet Financials | |
$206.54M |
|
$1.33M |
|
$13.28M |
|
$219.82M |
|
$22.80M |
|
$24.88M |
|
$31.47M |
|
$54.27M |
|
$165.55M |
|
$165.55M |
|
$165.55M |
|
61.57M |
|
| Cash Flow Statement Financials | |
$-81.90M |
|
$-14.07M |
|
$3.69M |
|
$124.64M |
|
$32.36M |
|
$-92.29M |
|
$6.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.06 |
|
|
Non-Performing Assets / Total Loans |
-- |
-- |
|
0.13 |
|
0.15 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-82.20M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-23.15% |
|
-23.15% |
|
-17.43% |
|
-20.12% |
|
$2.69 |
|
$-1.35 |
|
$-1.34 |
|